MIRA INFORM REPORT

 

 

Report Date :

02.07.2013

 

IDENTIFICATION DETAILS

 

Name :

SIGMA LABORATORIES LIMITED (w.e.f. 01.07.2000)

 

 

Formerly Known As :

SIGMA LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

43 (South), R A Kidwai Road, Wadala, Mumbai-400031, Maharashtra.

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

30.03.1987

 

 

Com. Reg. No.:

11-043007

 

 

Capital Investment / Paid-up Capital :

Rs. 170.000 Millions

 

 

CIN No.:

[Company Identification No.]

U85195MH1987PLC043007

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS23276B

 

 

PAN No.:

[Permanent Account No.]

AABCS4404L

 

 

Legal Form :

A Closely Held Public Limited Liability Company.

 

 

Line of Business :

Manufacturing and Marketing of Pharmaceutical Products. 

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 290000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record. There appears to be some accumulated losses recorded by the company. However, trade relations are fair. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Management non co-operative

 

 

 

LOCATIONS

 

Registered Office :

43 (South), R A Kidwai Road, Wadala, Mumbai-400031, Maharashtra, India

Tel. No.:

91-22-24181609

Fax No.:

91-22-24164250

E-Mail :

sigmaaccounts@rediffmail.com

Location :

Owned

 

 

Factory  :

6,7,8, Tivim Industrial Estate, Mafsa, Goa, Maharashtra, India

Location :

Owned

 

 

DIRECTORS

 

AS ON 27.09.2012

 

Name :

Mr. Dilip Shrinivas Coulagi

Designation :

Director

Address :

43 (South), R A Kidwai Road, Wadala, Mumbai-400031, Maharashtra, India

Date of Birth/Age :

15.06.1943

Date of Appointment :

22.04.2010

PAN No:

AAFPC6564J

DIN No.:

00557172

 

 

Name :

Mr. Gunvantrai Amritlal Sanghrajka

Designation :

Director

Address :

E1, Breachcandy Apartments, Bhulabhai Desai Road, Mumbai-400025, Maharashtra, India

Date of Birth/Age :

21.10.1935

Date of Appointment :

20.03.2003

DIN No.:

00322600

 

 

Name :

Mr. Ramesh Govindrao Kulkarni

Designation :

Director

Address :

9, Nirvana, 5th Floor, Junction of 24th and 30th Road, Bandra (West), Mumbai-400050, Maharashtra, India

Date of Birth/Age :

27.09.1930

Date of Appointment :

08.09.2009

DIN No.:

02789427

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 27.09.2012

 

Names of Equity Shareholders

No. of Shares

Dilip S. Coulagi

8588910

Sharayu S. Coulagi

109970

Tejus D Coulagi

20

Nayana D Coulagi

501010

Kavita D Coulagi

20

Priya D Coulagi

20

Sushama S Coulagi

50

Industrial Development Bank of India

800000

TOTAL

10000000

 

 

Names of Shareholders (8% Optionally Convertible / Redeemable Cumulative Preference Shares)

No. of Shares

Dilip S. Coulagi

500000

Nayana D Coulagi

200000

TOTAL

700000

 

 

AS ON 27.09.2012

 

Equity Shares Break Up

Percentage of Holding

Public financial companies

8.00

Directors or relatives of Directors

92.00

TOTAL

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Marketing of Pharmaceutical Products. 

 

 

Products :

Ø  Calcitab

Ø  Loracler Hayfever

Ø  Duoflam Gel

 

 

PRODUCTION STATUS (AS ON : 31.03.2011)

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Tablet

Lac

1200.00

1200.00

875.774

Ointments

Nos. in Lac

36.000

3.00

68.007

Syrup

In 000 liters

--

--

32.148

Ampoules and Vials

In Lac

--

--

16.274

 

 

GENERAL INFORMATION

 

No. of Employees :

Information denied by the management

 

 

Bankers :

  • HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai-400013, Maharashtra, India

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Paranjape and Paranjpe

Chartered Accountant

Address :

4, Jayram Niwas Cooperative Housing Society, 116, Tilak Mandir Road, Vile Parle (East), Mumbai-400057, Maharashtra, India 

PAN No.:

AAAFP2179H

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

13000000

Equity Shares

Rs.10/- each

Rs. 130.000 Millions

700000

8% Optionally Convertible / Redeemable Cumulative Preference Shares

Rs.100/- each

Rs. 70.000 Millions

 

TOTAL

 

Rs. 200.000 Millions

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs. 100.000 Millions

700000

8% Optionally Convertible / Redeemable Cumulative Preference Shares

Rs.100/- each

Rs. 70.000 Millions

 

TOTAL

 

Rs. 170.000 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

170.000

170.000

(b) Reserves & Surplus

 

(96.424)

(95.032)

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

73.576

74.968

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

4.370

0.000

Total Non-current Liabilities (3)

 

4.370

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

68.606

81.000

(b) Trade payables

 

12.345

12.454

(c) Other current liabilities

 

11.526

10.870

(d) Short-term provisions

 

11.494

10.940

Total Current Liabilities (4)

 

103.971

115.264

 

 

 

 

TOTAL

 

181.917

190.232

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

101.966

108.606

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(b) Non-current Investments

 

0.081

0.081

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

102.047

108.687

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

16.141

14.445

(c) Trade receivables

 

23.510

27.637

(d) Cash and cash equivalents

 

3.242

8.880

(e) Short-term loans and advances

 

36.977

30.583

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

79.870

81.545

 

 

 

 

TOTAL

 

181.917

190.232

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

170.000

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

1.197

4] (Accumulated Losses)

 

 

(176.014)

NETWORTH

 

 

(4.817)

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

183.158

TOTAL BORROWING

 

 

183.158

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

178.341

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

111.256

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.099

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

10.206

 

Sundry Debtors

 

 

55.939

 

Cash & Bank Balances

 

 

5.676

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

29.844

Total Current Assets

 

 

101.665

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

15.260

 

Other Current Liabilities

 

 

13.756

 

Provisions

 

 

5.663

Total Current Liabilities

 

 

34.679

Net Current Assets

 

 

66.986

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

178.341

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

88.646

82.609

123.390

 

 

Other Income

15.920

95.678

13.891

 

 

TOTAL                                     (A)

104.566

178.287

137.281

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of materials consumed

23.412

26.695

106.511

 

 

Purchases of stock-in-trade

0.080

0.000

 

 

 

Employee benefit expense

32.559

25.592

 

 

 

Other expenses

38.497

38.250

 

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(0.329)

(4.571)

 

 

 

TOTAL                                     (B)

94.219

85.966

106.511

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

10.347

92.321

30.770

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

11.739

12.536

13.396

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                (G)

(1.392)

79.785

17.374

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

(1.392)

79.785

17.374

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(96.229)

(176.014)

(193.388)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(97.621)

(96.229)

(176.014)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

NA

79.340

93.894

 

 

Recovery of Freight and Insurance

NA

3.270

8.578

 

TOTAL EARNINGS

NA

82.610

102.472

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

1.004

2.120

 

TOTAL IMPORTS

NA

1.004

2.120

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(0.13)

7.46

1.62

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

(1.33)

(44.75)

12.66

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(1.57)

(96.58)

14.08

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(0.77)

(41.96)

8.16

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.02)

(1.06)

(3.61)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.93

1.08

(38.02)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.77

0.71

2.93

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

FACILITIES

 

Unsecured Loan

 

Rs. In Millions

31.03.2012

Rs. In Millions

31.03.2011

SHORT TERM BORROWINGS

 

 

Loans and advances from related parties

68.606

81.000

 

 

 

TOTAL

68.606

81.000

 

 

SUNDRY CREDITORS DETAILS

(Rs. In Millions)

Particulars

 

31.03.2012

31.03.2011

31.03.2010

Sundry Creditors

12.345

12.454

15.260

TOTAL

12.345

12.454

15.260

 

 

BACKGROUND

 

The Company was incorporated on 13TH March, 1987 to manufacture and market its own pharmaceutical products in domestic and overseas markets. Currently, the company is engaged in exporting its products in international markets.

 

OPERATIONS AND OUTLOOK

 

As expressed in last year’s report, the figures for the year and the earlier year are not comparable as there was a very substantial exceptional one time item in the earlier year which boosted other income and profits. Absent such an item, this year’s operations show a modest loss.

 

The sales have gone up marginally, and with efforts continuing for registration of more products in existing and new markets, sales will continue to go up, but in the current year, the picture is clouded due to the loss of subleasing income, which will reduce other income substantially , which may lead to a loss again, despite good rise in sales.

 

However, the operations of the Company are likely to produce positive cash flow in view of the very substantial depreciation. Depending on product registrations, large capital expenditure might be required in the near future, though this is likely to arise in the next financial year rather than the current one, and will require borrowing funds from the bank, with concomitant financial cost outflow with the contribution from new registrations coming in with a lag in time; this will have to be reduced to a minimum as also various economy measures and cost reductions will

be needed; these are being pursed vigorously.

 

 

FORM 8

 

Corporate identity number of the company

U85195MH1987PLC043007

Name of the company

SIGMA LABORATORIES LIMITED

Address of the registered office or of the principal place of  business in India of the company

43 (South), R A Kidwai Road, Wadala, Mumbai-400031, Maharashtra, India

This form is for

Creation of charge

Type of charge

  • Book debts
  • Movable property (not being pledge)
  • Floating charge

Particular of charge holder

HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai-400013, Maharashtra, India

Nature of instrument creating charge

Letter of Hypothecation.

Date of instrument Creating the charge

22.11.2012

Amount secured by the charge

Rs. 20.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest

Interest at the rate as may be communicated by the Bank from time to time.

 

Terms of repayment

On demand.

 

Margin

As may be stipulated by the Bank from time to time.

 

Extent and operation of the charge

Hypothecation by way of First Charge on Stocks and Book Debts to secure as a continuing security as for the repayment of Rs.20.000 Millions together with interest, costs, charges, expenses and other moneys due and payable by the Company to the Bank.

Short particulars of the property charged (Including location of the property)

Stock-in-trade, consisting of raw materials, goods in process of manufacturing finished goods, and other merchandise whatsoever being movable properties, now

 

All the Debts, that is, all the book debts, out standings, monies receivables, claims,  bills, invoice documents, contracts, guarantees, and rights which are now

 

FIXED ASSETS

 

  • Land – Leasehold
  • Buildings
  • Plant and Machinery
  • Furniture and Fittings
  • Vehicles 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 59.14

UK Pound

1

Rs. 90.05

Euro

1

Rs. 77.06

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Report Prepared by :

DPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.